CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond
Author:
Funder
National Institutes of Health
Publisher
Elsevier BV
Subject
Molecular Biology,Molecular Medicine
Reference164 articles.
1. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias;Brentjens;Blood,2011
2. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor;Kochenderfer;J. Clin. Oncol.,2015
3. Chimeric antigen receptor T cells against CD19 for multiple myeloma;Garfall;N. Engl. J. Med.,2015
4. Immunotherapy of non-Hodgkins lymphoma with a defined ratio of CD8+ and CD4 + CD19-specific chimeric antigen receptor-modified T cells;Turtle;Sci. Transl. Med.,2016
5. Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL;Wang;Blood,2016
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer;Current Issues in Molecular Biology;2023-11-12
2. Successes and challenges in clinical gene therapy;Gene Therapy;2023-11
3. The estimated annual financial impact of gene therapy in the United States;Gene Therapy;2023-11
4. Development of CD30 CAR-T cells in refractory or relapsed Hodgkin’s lymphoma;Expert Review of Hematology;2023-10-30
5. Neurological adverse effects of chimeric antigen receptor T-cell therapy;Expert Review of Clinical Immunology;2023-09-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3